Epigenetics Market Worth $ 3.9 Billion by 2027 - Global Trend, Business Analysis, Recent Development, Share Analysis
In 2022, PacBio introduced DNA methylation capabilities via its product line, Sequel, in the US. Introducing this feature to the Sequel systems is expected to extend the accessibility of epigenomes via HiFi sequencing developed by the company.
View full press release